Paper10024596
Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.
Mansouri E and 9 others. Infect Immun, 1999. Cited by 67 papers, by iCite.
Cite this record
ConductScience Library. Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers. Papers, record 10024596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10024596
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Proteins | Major topic |
| Bacterial Vaccines | Major topic |
| Lipoproteins | Major topic |
| Porins | Major topic |
| Pseudomonas aeruginosa | Major topic |
| Recombinant Fusion Proteins | Major topic |
| Vaccines, Synthetic | Major topic |
| Adult | |
| Antibodies, Bacterial | |
| Female | |
| Humans | |
| Male | |
| Phagocytosis | |
| Vaccination |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3131471 | Characterization of the human immune response to a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine. | J Lab Clin Med | 1988 | https://conductscience.org/library/papers/3131471 | PubMed |
| 2 | 1730152 | Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3. | Clin Immunol Immunopathol | 1992 | https://conductscience.org/library/papers/1730152 | PubMed |
| 3 | 7729895 | Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins. | Infect Immun | 1995 | https://conductscience.org/library/papers/7729895 | PubMed |
| 4 | 91774 | Controlled trials of a polyvalent pseudomonas vaccine in burns. | Lancet | 1979 | https://conductscience.org/library/papers/91774 | PubMed |
| 5 | 9437483 | Nosocomial infections in an oncology intensive care unit. | Am J Infect Control | 1997 | https://conductscience.org/library/papers/9437483 | PubMed |
| 6 | 2602775 | Pseudomonas bacteremia in a community teaching hospital, 1980-1984. | Rev Infect Dis | 1989 | https://conductscience.org/library/papers/2602775 | PubMed |
| 7 | 8063415 | Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine. | Infect Immun | 1994 | https://conductscience.org/library/papers/8063415 | PubMed |
| 8 | 9456102 | Secular trends in nosocomial bloodstream infections in a 55-bed cardiothoracic intensive care unit. | Ann Thorac Surg | 1998 | https://conductscience.org/library/papers/9456102 | PubMed |
| 9 | 9673254 | Complex serology and immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strains. | Infect Immun | 1998 | https://conductscience.org/library/papers/9673254 | PubMed |
| 10 | 3102446 | Intrinsic antibiotic resistance of Pseudomonas aeruginosa. | J Antimicrob Chemother | 1986 | https://conductscience.org/library/papers/3102446 | PubMed |
| 11 | 8911006 | Safety and immunogenicity of a Pseudomonas aeruginosa outer membrane protein I vaccine in human volunteers. | Vaccine | 1996 | https://conductscience.org/library/papers/8911006 | PubMed |
| 12 | 9571743 | High incidence of antibiotic resistance among bacteria in 4 intensive care units at a university hospital in Sweden. | Scand J Infect Dis | 1997 | https://conductscience.org/library/papers/9571743 | PubMed |
| 13 | 2733597 | Octavalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine. | Microb Pathog | 1989 | https://conductscience.org/library/papers/2733597 | PubMed |
| 14 | 2210853 | Nosocomial infections in general surgery: surveillance report from a German university clinic. | Infection | 1990 | https://conductscience.org/library/papers/2210853 | PubMed |
| 15 | 2449095 | Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. | Anal Biochem | 1987 | https://conductscience.org/library/papers/2449095 | PubMed |
| 16 | 11000453 | Immunogenic efficacy of differently produced recombinant vaccines candidates against Pseudomonas aeruginosa infections. | J Biotechnol | 2000 | https://conductscience.org/library/papers/11000453 | PubMed |
| 17 | 2511252 | The epidemiology of Pseudomonas aeruginosa in oncology patients in a general hospital. | J Infect Dis | 1989 | https://conductscience.org/library/papers/2511252 | PubMed |
| 18 | 1438580 | Molecular and cellular basis of immune protection of mucosal surfaces. | Physiol Rev | 1992 | https://conductscience.org/library/papers/1438580 | PubMed |
| 19 | 7839727 | Protection of immunosuppressed mice against translocation of Pseudomonas aeruginosa from the gut by oral immunization with recombinant Pseudomonas aeruginosa outer membrane protein I expressing Salmonella dublin. | Vaccine | 1994 | https://conductscience.org/library/papers/7839727 | PubMed |
| 20 | 402473 | A new polyvalent Pseudomonas vaccine. | J Med Microbiol | 1977 | https://conductscience.org/library/papers/402473 | PubMed |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42750463 | Targeting Outer Membrane Vesicles of Pseudomonas aeruginosa: From Pathogenesis to Therapeutics. | J Microbiol Biotechnol | 2026 | https://conductscience.org/library/papers/42750463 | PubMed |
| 41599011 | Taming Superbugs: Current Progress and Challenges in Combating ESKAPE Pathogens. | Pathogens | 2025 | https://conductscience.org/library/papers/41599011 | PubMed |
| 41498839 | Bibliometric analysis of Pseudomonas aeruginosa vaccine development highlighting research status, evolution, and future opportunities. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41498839 | PubMed |
| 40076637 | Pseudomonas aeruginosa Vaccine Development: Lessons, Challenges, and Future Innovations. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40076637 | PubMed |
| 37515079 | The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/37515079 | PubMed |
| 36258075 | Pseudomonas aeruginosa Antivirulence Strategies: Targeting the Type III Secretion System. | Adv Exp Med Biol | 2022 | https://conductscience.org/library/papers/36258075 | PubMed |
| 36069593 | Multicomponent Pseudomonas aeruginosa Vaccines Eliciting Th17 Cells and Functional Antibody Responses Confer Enhanced Protection against Experimental Acute Pneumonia in Mice. | Infect Immun | 2022 | https://conductscience.org/library/papers/36069593 | PubMed |
| 35891262 | Pseudomonas aeruginosa: Recent Advances in Vaccine Development. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/35891262 | PubMed |
| 33972378 | Cell-free expression of the outer membrane protein OprF of Pseudomonas aeruginosa for vaccine purposes. | Life Sci Alliance | 2021 | https://conductscience.org/library/papers/33972378 | PubMed |
| 33291484 | Understanding Pseudomonas aeruginosa-Host Interactions: The Ongoing Quest for an Efficacious Vaccine. | Cells | 2020 | https://conductscience.org/library/papers/33291484 | PubMed |
| 32131866 | Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients-a randomized clinical trial. | Crit Care | 2020 | https://conductscience.org/library/papers/32131866 | PubMed |
| 30814874 | Recombinant outer membrane protein Q and putative lipoprotein from Bordetella pertussis inducing strong humoral response were not protective alone in the murine lung colonization model. | Turk J Biol | 2018 | https://conductscience.org/library/papers/30814874 | PubMed |
| 30314911 | PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen improves Th17 responses and confers protection against experimental acute pneumonia. | Vaccine | 2018 | https://conductscience.org/library/papers/30314911 | PubMed |
| 30008053 | Recombinant helical plant virus-based nanoparticles for vaccination and immunotherapy. | Virus Genes | 2018 | https://conductscience.org/library/papers/30008053 | PubMed |
| 28159015 | A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients. | Crit Care | 2017 | https://conductscience.org/library/papers/28159015 | PubMed |
| 26855594 | Pseudomonas aeruginosa ventilator-associated pneumonia management. | Infect Drug Resist | 2016 | https://conductscience.org/library/papers/26855594 | PubMed |
| 25964476 | Identification of OprF as a complement component C3 binding acceptor molecule on the surface of Pseudomonas aeruginosa. | Infect Immun | 2015 | https://conductscience.org/library/papers/25964476 | PubMed |
| 24575895 | Vaccines for Pseudomonas aeruginosa: a long and winding road. | Expert Rev Vaccines | 2014 | https://conductscience.org/library/papers/24575895 | PubMed |
| 24064511 | A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers. | Hum Vaccin Immunother | 2014 | https://conductscience.org/library/papers/24064511 | PubMed |
| 23607394 | RGD capsid modification enhances mucosal protective immunity of a non-human primate adenovirus vector expressing Pseudomonas aeruginosa OprF. | Clin Exp Immunol | 2013 | https://conductscience.org/library/papers/23607394 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| C1QA | 712 | PubTator's text mining | https://conductscience.org/library/genes/712 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10024596
GET https://conductscience.org/api/papers/v1/10024596/references?page=2